Work

Treatment ofEGFR-Mutant Lung Cancers After Progression in Patients Receiving First-Line EGFR Tyrosine Kinase Inhibitors

Year: 2016

Type: article

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2016.0333

Authors: Zofia Piotrowska, Lecia V. Sequist

Institutions: Harvard University, Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2399742010

FWCI: 4.78

Cites: 60

Cited by: 40

Related to: 10